These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29545333)

  • 1. A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in
    Inoue A; Mizushima T; Wu X; Okuzaki D; Kambara N; Ishikawa S; Wang J; Qian Y; Hirose H; Yokoyama Y; Ikeshima R; Hiraki M; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
    Mol Cancer Ther; 2018 May; 17(5):977-987. PubMed ID: 29545333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-29b Mediates NF-κB Signaling in KRAS-Induced Non-Small Cell Lung Cancers.
    Langsch S; Baumgartner U; Haemmig S; Schlup C; Schäfer SC; Berezowska S; Rieger G; Dorn P; Tschan MP; Vassella E
    Cancer Res; 2016 Jul; 76(14):4160-9. PubMed ID: 27199349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
    Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB maintains the stemness of colon cancer cells by downregulating miR-195-5p/497-5p and upregulating MCM2.
    Wang L; Guo J; Zhou J; Wang D; Kang X; Zhou L
    J Exp Clin Cancer Res; 2020 Oct; 39(1):225. PubMed ID: 33109220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs-Based Molecular Signature for
    Milanesi E; Dobre M; Bucuroiu AI; Herlea V; Manuc TE; Salvi A; De Petro G; Manuc M; Becheanu G
    J Immunol Res; 2020; 2020():4927120. PubMed ID: 32676506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
    Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
    Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
    Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D
    J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of LncRNA CASC2 mediated the cell viability, apoptosis and autophagy of colon cancer cells by sponging miR-19a via NF-κB signaling pathway.
    Zhang P; Pan Y; Sun J; Pan G
    Int J Exp Pathol; 2021 Jun; 102(3):163-171. PubMed ID: 33983643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YWHAE long non-coding RNA competes with miR-323a-3p and miR-532-5p through activating K-Ras/Erk1/2 and PI3K/Akt signaling pathways in HCT116 cells.
    Bjeije H; Soltani BM; Behmanesh M; Zali MR
    Hum Mol Genet; 2019 Oct; 28(19):3219-3231. PubMed ID: 31238337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis.
    Zhao C; Zhao Q; Zhang C; Wang G; Yao Y; Huang X; Zhan F; Zhu Y; Shi J; Chen J; Yan F; Zhang Y
    Sci Rep; 2017 Jun; 7(1):4194. PubMed ID: 28646148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-5p and -3p co-expression and cross-targeting in colon cancer cells.
    Choo KB; Soon YL; Nguyen PN; Hiew MS; Huang CJ
    J Biomed Sci; 2014 Oct; 21(1):95. PubMed ID: 25287248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cells.
    Morimoto Y; Mizushima T; Wu X; Okuzaki D; Yokoyama Y; Inoue A; Hata T; Hirose H; Qian Y; Wang J; Miyoshi N; Takahashi H; Haraguchi N; Matsuda C; Doki Y; Mori M; Yamamoto H
    Br J Cancer; 2020 Mar; 122(7):1037-1049. PubMed ID: 32066912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.
    Choi YW; Song YS; Lee H; Yi K; Kim YB; Suh KW; Lee D
    Medicine (Baltimore); 2016 Apr; 95(15):e3321. PubMed ID: 27082577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer.
    Zhang L; Dong Y; Zhu N; Tsoi H; Zhao Z; Wu CW; Wang K; Zheng S; Ng SS; Chan FK; Sung JJ; Yu J
    Mol Cancer; 2014 May; 13():124. PubMed ID: 24885920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR.
    Tang YJ; Wu W; Chen QQ; Liu SH; Zheng ZY; Cui ZL; Xu JP; Xue Y; Lin DH
    BMC Cancer; 2022 Aug; 22(1):909. PubMed ID: 35986311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
    Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
    Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEK and TAK1 Regulate Apoptosis in Colon Cancer Cells with KRAS-Dependent Activation of Proinflammatory Signaling.
    McNew KL; Whipple WJ; Mehta AK; Grant TJ; Ray L; Kenny C; Singh A
    Mol Cancer Res; 2016 Dec; 14(12):1204-1216. PubMed ID: 27655129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulatory roles of miRNA and methylation on oncogene and tumor suppressor gene expression in pancreatic cancer cells.
    Wang X; Zhao J; Huang J; Tang H; Yu S; Chen Y
    Biochem Biophys Res Commun; 2012 Aug; 425(1):51-7. PubMed ID: 22820191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
    Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS
    Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP.
    Choe MH; Yoon Y; Kim J; Hwang SG; Han YH; Kim JS
    Cell Death Dis; 2018 May; 9(6):640. PubMed ID: 29844307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.